Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

Clinical trial NCT02599324 · COMPLETED

Trial details

NCT number: NCT02599324
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma Advanced Urothelial Carcinoma Advanced Gastric Adenocarcinoma Metastatic Colorectal Adenocarcinoma

Start date: 2015-12-01
Primary completion: 2021-08-20
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.